London
19 °C
Manchester
18 °C
Glasgow
17 °C
Dublin
Belfast
20 °C
Washington
21 °C
Denver
Atlanta
Dallas
Houston Texas
New Orleans
El Paso
Phoenix
Los Angeles
27 °C
16 °C
12 °C
13 °C
Featured
Last news
New Syria leader vows state 'monopoly' on weapons
Syria's new interim president pledged on Tuesday to ensure the state has a monopoly on weapons at a national dialogue conference on the country's future after Bashar al-Assad's overthrow.
Ailing pope resting amid slight improvement: Vatican
A critically ill Pope Francis, battling pneumonia in both lungs, slept well, the Vatican said Tuesday after earlier reporting a "slight improvement" in the health of the 88-year-old.
Ailing pope 'rested well' amid improvement: Vatican
A critically ill Pope Francis, who is battling pneumonia in both lungs, "rested well", the Vatican said Tuesday after earlier reporting a "slight improvement" in the condition of the 88-year-old.
Milan Fashion week opens as luxury sector struggles
Flair and fanfare promise to light up the Milan Fashion Week catwalks starting Tuesday, but upcoming shows will struggle to distract from a worrying slump in the luxury sector.
What happens next in S. Korea as Yoon's impeachment trial wraps up
South Korea's ousted President Yoon Suk Yeol's impeachment trial wraps up on Tuesday, capping weeks of high political drama following his shock decision to declare martial law.
Judge declines to immediately grant AP access to White House events
A US judge on Monday declined to immediately order the White House to restore full access to President Donald Trump's events to the Associated Press news agency.
MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada
HALIFAX, NS / ACCESS Newswire / February 25, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today its exclusive distribution agreement with Trimedic Inc. for the Canadian market. This partnership allows MedMira to expedite its growth in the Canadian market with the recently Health Canada approved Multiplo® TP/HIV rapid antibody test and its Reveal® G4 HIV-1/2 rapid antibody test. Both products have been granted Class 4 Medical Device Licenses, the highest regulatory classification for medical diagnostics in Canada.
1933 Industries Announces Fourth Quarter and 2024 Year-End Financial Results with Record Revenues of $19.3 Million
VANCOUVER, BC / ACCESS Newswire / February 25, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its fourth quarter ("Q4 2024") and audited annual financial results for the years ended July 31, 2024 and 2023 ("Fiscal 2024"). All amounts expressed are in Canadian dollars.
CGFNS International to Change Its Name to TruMerit
Rebranding heralds greater focus on building a future-ready global healthcare workforce
Xebra Brands Unveils Strategic 2025 Roadmap to Accelerate Growth in North American CBD Market
VANCOUVER, BC / ACCESS Newswire / February 25, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0) is pleased to announce the development of the Strategic 2025 Roadmap, a comprehensive commercial growth plan designated to expand its footprint in the North American CBD market. Developed in collaboration with a consulting firm specializing in Cannabis and CBD, the Strategic 2025 Roadmap outlines a clear roadmap to drive accelerated growth and market penetration. This strategic initiative positions Xebra to capitalize on emerging opportunities and strengthen its competitive presence in the rapidly evolving CBD industry.
CTT Pharma Gives Update On U.S. and European Patents
TAMPA, FL / ACCESS Newswire / February 25, 2025 / CTT Pharmaceutical Holdings, Inc. (OTC PINK:CTTH) has received notification of an intention to grant from the European Patent Office(EPO) for additional claims to our original European Patent. CTT Pharma already received an intention to grant from the EPO for our micelle delivery but opted to further define and strengthen our patent for diabetes related drugs. Since, the patent for the diabetes drug Liraglutide has expired CTT will seek to find opportunities to utilize our micelle technology for Liraglutide. CTT also believes our technology could offer an enhanced drug delivery system for pharmaceutical companies with current diabetes drugs that are patented and for drugs in development. Furthermore, CTT is actively working on strengthening our patents in the United States and Europe and will look to file provisional patents in 2025 to continue to protect and strengthen our technology. CTT will update shareholders on additional provisional patents once they are filed and how they will be used to help with future development.
LFTD Partners Entering Marijuana Industry in Illinois
Plans to acquire multiple Illinois Cannabis Licenses, a lease for marijuana product manufacturing in Skokie, IL, and industrial buildings and retail businesses in Rockford, IL
DR Congo PM says 'more than 7,000 dead' in war-torn east
DR Congo's prime minister said Monday that "more than 7,000" people have been killed in the east of the country since January, when the Rwanda-backed M23 group seized two major cities.
South Carolina to carry out first US firing squad execution since 2010
A South Carolina man convicted of murdering his ex-girlfriend's parents has chosen to be put to death by firing squad next month in what would be the first such execution in the United States since 2010.
EU vows to enforce digital rules despite Trump tariff warning
The EU promised on Monday to enforce its digital rules and to defend its laws "decisively" if necessary, after US President Donald Trump threatened to slap tariffs on countries that levy digital taxes on US tech firms.
Paedophile French surgeon in sex abuse trial admits to 'hideous' acts
A former French surgeon went on trial Monday charged with raping or sexually assaulting almost 300 patients, most of them children at the time, in one of the country's largest child sex abuse cases.
Upset stomach to overdose: A child's ordeal at France abuse trial
French retiree Roland Vinet is certain his grandson Mathis would still be alive if he had never met doctor Joel Le Scouarnec as a 10-year-old with an upset stomach.
Russian court upholds French researcher's jail sentence
A Russian court on Monday upheld a three-year prison sentence for French researcher Laurent Vinatier, one of several Westerners jailed by Russia during the Ukraine offensive.
Critically-ill pope had a good night, Vatican says
Pope Francis, hospitalised in critical condition with pneumonia in both lungs, spent a peaceful night and was "resting" Monday, the Vatican said amidst global concern over the pontiff's health.
Paedophile French surgeon on trial for abusing almost 300 patients
A former surgeon is to go on trial in France on Monday charged with raping or sexually assaulting almost 300 former patients, most of them children.
All Black Caleb Clarke admits dangerous driving: NZ media
All Blacks wing Caleb Clarke said he was "extremely apologetic" Monday after admitting to dangerous driving charges, New Zealand media reported.
India's Modi uses mega Hindu festival to burnish credentials
The quest of millions seeking salvation at the world's largest religious festival has also been a golden opportunity for Indian Prime Minister Narendra Modi to burnish Hindu nationalist credentials.
UniDoc - Announces Filing of Amended and Restated Interim Management Discussion and Analysis
VANCOUVER, BC / ACCESS Newswire / February 24, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), is issuing this news release to advise its shareholders that the Company has been subject to a continuous disclosure review by the British Columbia Securities Commission. In connection therewith, the Company has filed amended and restated management's discussion and analysis ("MD&A") for the six (6) month period ended September 30, 2024, to clarify its disclosure.
Onco-Innovations' PKNP Technology Shown in Study to Demonstrate Low Toxicity and High Safety Profile
VANCOUVER, BC / ACCESS Newswire / February 24, 2025 / Onco-Innovations Limited(CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to provide information regarding its second-generation nanoparticle formulation of Polynucleotide Kinase 3'-Phosphatase (PNKP) Compound (the "Technology"), specifically that it has demonstrated enhanced PNKP inhibitor delivery, enabling solubilization with minimal toxicity, in a June 2021 study[1] conducted by researchers at the University of Alberta, Canada. The study demonstrated that the Technology was well-tolerated, even at therapeutic doses to mice with colorectal cancer, making it a promising candidate for further research and development. This finding is highly relevant, as low toxicity indicates the potential for fewer side effects, potentially allowing for use to enhance more effective and safer treatment options.
Nepra Foods Partners with Industry Expert to Develop Proprietary Hemp Protein for Food Innovation
Breakthrough Ingredient Set to Redefine Plant-Based Nutrition in Baked Goods and Beyond
Nepra Foods' Chadwick White to Present on Hemp as a Food Ingredient at Cornell University Webinar
Innovative Leader in Plant-Based Nutrition to Share Insights on February 26, 2025
BioNxt Solutions Announces Debenture Unit Financing
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
LQR House Inc. Maintains Steady Year-Over-Year Revenue Despite Eliminating Paid Advertising, Showcasing SEO Strength While Advancing Profitability Strategy
MIAMI BEACH, FL / ACCESS Newswire / February 24, 2025 / LQR House Inc. (the "Company" or "LQR House") (NASDAQ:YHC), a niche ecommerce platform specializing in the spirits and beverage industry, today announced that despite completely eliminating paid advertising on Google and Meta in January 2025, its flagship website, CWSpirits.com, experienced only a 1.309% year-over-year revenue decline compared to January 2024. The Company believes that this outcome demonstrates the powerful impact of LQR House's advanced search engine optimization (SEO) strategy, as well as the strength of its proprietary UI/UX design and high-converting product offerings.
The Fresh Factory Announces US$3 Million Non-Brokered Private Placement
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
American Airlines flight lands in Rome after 'security' issue
An American Airlines flight from New York to New Delhi was diverted to Rome on Sunday afternoon following an "alleged bomb scare", an Italian airport spokesman said.
Global prayers as Vatican says pope still 'critical'
Pope Francis's condition "remains critical", the Vatican said Sunday on his 10th day in hospital as Catholics around the world prayed for the 88-year-old's recovery.
Global prayers for 'critically ill' pope
Pope Francis spent his tenth day in hospital Sunday as Catholics around the world prayed for his recovery, the day after the Vatican warned the 88-year-old's condition was "critical".